It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Nanoparticles from magnetotactic bacteria have been used in conventional imaging, drug delivery, and magnetic manipulations. Here, we show that these natural nanoparticles and their bioinspired hybrids with near-infrared gold nanorods and folic acid can serve as molecular high-contrast photoacoustic probes for single-cell diagnostics and as photothermal agents for single-cell therapy using laser-induced vapor nanobubbles and magnetic field as significant signal and therapy amplifiers. These theranostics agents enable the detection and photomechanical killing of triple negative breast cancer cells that are resistant to conventional chemotherapy, with just one or a few low-energy laser pulses. In studies in vivo, we discovered that circulating tumor cells labeled with the nanohybrids generate transient ultrasharp photoacoustic resonances directly in the bloodstream as the basis for new super-resolution photoacoustic flow cytometry in vivo. These properties make natural and bioinspired magnetic nanoparticles promising biocompatible, multimodal, high-contrast, and clinically relevant cellular probes for many in vitro and in vivo biomedical applications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 the University of Arkansas at Little Rock, Center for Integrative Nanotechnology Sciences, Little Rock, USA (GRID:grid.265960.e) (ISNI:0000 0001 0422 5627)
2 University of Arkansas for Medical Sciences, Arkansas Nanomedicine Center & Winthrop P. Rockefeller Cancer Institute, Little Rock, USA (GRID:grid.241054.6) (ISNI:0000 0004 4687 1637)
3 University of Arkansas for Medical Sciences, Arkansas Nanomedicine Center & Winthrop P. Rockefeller Cancer Institute, Little Rock, USA (GRID:grid.241054.6) (ISNI:0000 0004 4687 1637); Diagnosis and Therapy (LDT), University of Arkansas for Medical Sciences, Laboratory of Lymphatic Research, Little Rock, USA (GRID:grid.241054.6) (ISNI:0000 0004 4687 1637)